Systems and methods of determining alleles and/or copy numbers

• US 20070238106A1
• Filed: 04/07/2006
• Published: 10/11/2007
• Est. Priority Date: 04/07/2006
• Status: Abandoned Application

• Current Assignee: Agilent Technologies, Inc.
• Original Assignee: Agilent Technologies, Inc.
• Inventors: Barrett, Michael, Sampas, Nicholas
• Application Number:
  US11/400,532
• Publication Number:
  US 20070238106A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 2525/204 specific length of the oligonucleotides
• CPC Class Codes: C12Q 2535/131 Allele specific probes
• CPC Class Codes: C12Q 2565/513 characterised by the pattern of the arrayed oligonucleotides

Abstract

Various aspects of the invention include a solid support having a first region with a first nucleic acid, and second, third, fourth and fifth regions having, respectively, second, third, fourth, and fifth nucleic acids each having a length that is shorter than the length of the first nucleic acid. Certain aspects of the invention further include embodiments where the second, third, fourth, and fifth nucleic acids are substantially identical, and no two of the second, third, fourth, and fifth nucleic acids ends with identical terminal nucleotides. Some aspects of the invention further include methods of using the solid support, and kits that include the same.

Claims

1. A solid support, comprising:

in a first region, a first nucleic acid; and

in second, third, fourth, and fifth regions, respectively, second, third, fourth, and fifth nucleic acids, each having a length that is shorter than the length of the first nucleic acid, each being immobilized relative to the solid support at a first end of each respective nucleic acid, each of the second, third, fourth, and fifth nucleic acids being substantially identical, wherein no two of the second, third, fourth, and fifth nucleic acids ends with identical terminal nucleotides.

2. The solid support of claim 1, wherein each of the second, third, fourth, and fifth nucleic acids is less than about two-thirds of the length of the first nucleic acid.

3. The solid support of claim 1, wherein each of the second, third, fourth and fifth nucleic acids are less than about one-half of the length of the first nucleic acid.

4. The solid support of claim 1, wherein the first nucleic acid has a length of between 40 nucleotides and 200 nucleotides, inclusive.

5. The solid support of claim 4, wherein the first nucleic acid has between 45 nucleotides and 60 nucleotides, inclusive.

6. The solid support of claim 1, wherein each of the second, third, fourth and fifth nucleic acids has between 20 nucleotides and 50 nucleotides, inclusive.

7. The solid support of claim 6, wherein each of the second, third, fourth, and fifth nucleic acids has between 20 nucleotides and 35 nucleotides, inclusive.

8. The solid support of claim 1, wherein each of the second, third, fourth, and fifth nucleic acids are identical except for the terminal nucleotides.

9. The solid support of claim 1, wherein the solid support is a microarray.

10. The solid support of claim 1, further comprising a first detection entity immobilized relative to the first nucleic acid.

11. The solid support of claim 1, wherein each of the second, third, fourth, and fifth nucleic acids has a second detection entity immobilized relative thereto.

12. A method, comprising acts of:

providing a first nucleic acid;

providing at least three types of substantially identical nucleic acid probes, each having a length that is shorter than the length of the first nucleic acid no two of the at least three types of substantially identical nucleic acid probes ending with identical terminal nucleotides;

hybridizing a target nucleic acid to at least some of the nucleic acid probes, the target nucleic acid having a length greater than the length of the nucleic acid probes;

substantially complementarily extending one of the probe nucleic acids along the target nucleic acid, without substantially extending the length of the other probe nucleic acids by subjecting the probe nucleic acids to primer extension reaction conditions;

evaluating binding of the target nucleic acid and the first nucleic acid; and

evaluating binding of the target acid with the nucleic acid probes.

13. The method of claim 12, wherein the first nucleic acid has a length of between 40 nucleotides and 200 nucleotides, inclusive.

14. The method of claim 12, comprising providing at least four types of substantially identical nucleic acid probes, each having a length of between 20 nucleotides and 50 nucleotides, inclusive, no two of the at least four types of substantially identical nucleic acid probes ending with identical terminal nucleotides.

15. The method of claim 12, wherein each of the at least three types of nucleic acid probes are identical except for the terminal nucleotides.

16. The method of claim 12, comprising hybridizing the target nucleic acid to the first nucleic acid.

17. The method of claim 12, further comprising immobilizing a first detection entity with respect to the first nucleic acid.

18. The method of claim 12, comprising identifying a SNP of the target nucleic acid by determining association of the target acid with one of the at least three types of substantially identical nucleic acid probes.

19. A solid support, comprising:

in first, second, third, fourth, and fifth regions, respectively, first, second, third, fourth, and fifth nucleic acids, each of the second, third, fourth, and fifth nucleic acids being substantially identical and having between 20 nucleotides and 50 nucleotides, inclusive, wherein the first nucleic acid comprises a portion substantially identical to the second, third, fourth, and fifth nucleic acids.

20. A kit, comprising:

a first nucleic acid; and

second, third, fourth, and fifth nucleic acids, each having a length that is shorter than the length of the first nucleic acid, each of the second, third, fourth, and fifth nucleic acid being substantially identical, wherein no two of the second, third, fourth, and fifth nucleic acids ends with identical terminal nucleotides.